JP2022533939A5 - - Google Patents

Info

Publication number
JP2022533939A5
JP2022533939A5 JP2021567059A JP2021567059A JP2022533939A5 JP 2022533939 A5 JP2022533939 A5 JP 2022533939A5 JP 2021567059 A JP2021567059 A JP 2021567059A JP 2021567059 A JP2021567059 A JP 2021567059A JP 2022533939 A5 JP2022533939 A5 JP 2022533939A5
Authority
JP
Japan
Application number
JP2021567059A
Other languages
Japanese (ja)
Other versions
JP2022533939A (ja
JPWO2020236524A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/032939 external-priority patent/WO2020236524A1/en
Publication of JP2022533939A publication Critical patent/JP2022533939A/ja
Publication of JPWO2020236524A5 publication Critical patent/JPWO2020236524A5/ja
Publication of JP2022533939A5 publication Critical patent/JP2022533939A5/ja
Pending legal-status Critical Current

Links

JP2021567059A 2019-05-17 2020-05-14 線維芽細胞増殖因子受容体キナーゼの阻害剤 Pending JP2022533939A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962849534P 2019-05-17 2019-05-17
US62/849,534 2019-05-17
US201962907491P 2019-09-27 2019-09-27
US62/907,491 2019-09-27
PCT/US2020/032939 WO2020236524A1 (en) 2019-05-17 2020-05-14 Inhibitors of fibroblast growth factor receptor kinases

Publications (3)

Publication Number Publication Date
JP2022533939A JP2022533939A (ja) 2022-07-27
JPWO2020236524A5 JPWO2020236524A5 (https=) 2023-05-08
JP2022533939A5 true JP2022533939A5 (https=) 2023-05-08

Family

ID=73458745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021567059A Pending JP2022533939A (ja) 2019-05-17 2020-05-14 線維芽細胞増殖因子受容体キナーゼの阻害剤

Country Status (7)

Country Link
US (1) US20230174535A1 (https=)
EP (1) EP3969442A4 (https=)
JP (1) JP2022533939A (https=)
CN (1) CN114127051A (https=)
AU (1) AU2020278566A1 (https=)
CA (1) CA3139161A1 (https=)
WO (1) WO2020236524A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
EP4161657A1 (en) * 2020-06-05 2023-04-12 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases
IL298760A (en) 2020-06-05 2023-02-01 Kinnate Biopharma Inc Fibroblast growth factor receptor kinase inhibitors
WO2023107870A1 (en) * 2021-12-08 2023-06-15 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases
AU2022407440A1 (en) * 2021-12-08 2024-06-20 Kinnate Biopharma Inc. Solid state forms of an fgfr inhibitor
WO2024109799A1 (zh) * 2022-11-22 2024-05-30 西藏海思科制药有限公司 一种嘧啶衍生物及其在医药上的应用
WO2025024665A1 (en) * 2023-07-26 2025-01-30 Kinnate Biopharma Inc. Treatment of cancer with a cdk inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI378934B (en) * 2004-04-02 2012-12-11 Osi Pharm Inc 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
US7723336B2 (en) * 2005-09-22 2010-05-25 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
US20070078136A1 (en) * 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
KR101461680B1 (ko) * 2005-12-02 2014-11-19 바이엘 헬스케어 엘엘씨 과다-증식성 장애 및 맥관형성과 관련된 질환의 치료에유용한 치환된 4-아미노-피롤로트리아진 유도체
DK2657233T3 (da) * 2012-01-19 2014-09-22 Taiho Pharmaceutical Co Ltd 3,5-disubstitueret alkynylbenzenforbindelse og salt deraf
GB201503590D0 (en) * 2015-03-03 2015-04-15 Davis Adrian Topical formulation
MY196077A (en) * 2015-03-31 2023-03-13 Taiho Pharmaceutical Co Ltd Crystal Of 3,5-Disubstituted Benzene Alkynyl Compound
WO2017139509A1 (en) * 2016-02-12 2017-08-17 Purdue Research Foundation Manipulating 3d virtual objects using hand-held controllers
CN107698593A (zh) * 2016-08-09 2018-02-16 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
US10685111B2 (en) * 2016-10-31 2020-06-16 Crowdstrike, Inc. File-modifying malware detection
CN110139865B (zh) * 2016-12-29 2022-02-18 石药集团中奇制药技术(石家庄)有限公司 Fgfr抑制剂

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2022533939A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)